Dana-Farber Leads Phase 3 Trials for Breast, Lung, and Bladder Cancer Unveiled at ESMO Congress 2025
Dana-Farber Cancer Institute’s groundbreaking research continues to shape the landscape of oncology as their experts present a series of pivotal ...